Cleerly Raises $106M in Funding Led by Insight Partners to Revolutionize Heart Disease Care

DENVER, CO, December 4, 2024 (PR Newswire) Cleery, a leader in advanced cardiovascular imaging, announced the successful closure of its Series C extension funding round, raising a total of $106 million. This funding round was led by global software investor Insight Partners and joined by Battery Ventures with participation from…Read More

Read More
Roper Technologies To Acquire Transact Campus To Be Combined with Roper’s CBORD Business

SARASOTA, FL August 15, 2024 (Global Newswire) Roper Technologies, Inc. (Nasdaq: ROP) today announced that it has entered into a definitive agreement to acquire Transact Campus, Inc. for a net purchase of $1.5 billion, including a $100 million tax benefit resulting from the transaction. The net purchase represented approximately 14…Read More

Read More
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies into Clinical Development

SEATTLE, WA, August 1, 2004 (Globe Newswire) Outpace Bio, a cell therapy company using unrivaled AI-powered protein design to program immune cells for improved function inside patients battling solid tumors, today announced that it has raised $144 million in an oversubscribed Series B financing. FLG partner Greg Curhan, assisted. Read…Read More

Read More
Cap Hill Brands Merges with Juvo+ to form Infinite Commerce

March 8, 2024 (Geekwire.com) – Seattle-based Cap Hill Brands, which raised more than $250 million to acquire and grow e-commerce shops, has merged with Juvo+, a company that focuses on developing and selling its own products online. Terms of the all-stock deal were not disclosed. The combined company is now…Read More

Read More
Nuvation Bio to Acquire AnHeart Therapeutics in All Stock Transaction

New York, NY, March 25, 2024 – Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, and AnHeart Therapeutics Ltd. (AnHeart), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, today…Read More

Read More